KN069

· Suzhou Alphamab Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KN069, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight [Phase 1]